Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
NDC API
0
VMF
0
FDA Orange Book
0
Canada
0
Australia
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Imeron
2. Iomeprol 350
3. Iomeprol 400
4. Iomeron
1. 78649-41-9
2. Iomeprolum
3. Iomeron
4. Imeron
5. Iomeron 300
6. N,n'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-5-(n-methylglycolamido)isophthalamide
7. N1,n3-bis(2,3-dihydroxypropyl)-5-(2-hydroxy-n-methylacetamido)-2,4,6-triiodoisophthalamide
8. E-7337
9. 1-n,3-n-bis(2,3-dihydroxypropyl)-5-[(2-hydroxyacetyl)-methylamino]-2,4,6-triiodobenzene-1,3-dicarboxamide
10. 17e17jbp8l
11. 1185146-41-1
12. Chebi:31710
13. N,n'-bis(2,3-dihydroxypropyl)-5-[glycoloyl(methyl)amino]-2,4,6-triiodoisophthalamide
14. Ncgc00183283-01
15. Iomeprolo
16. E7337
17. 1,3-benzenedicarboxamide, N,n'-bis(2,3-dihydroxypropyl)-5-((hydroxyacetyl)methylamino)-2,4,6-triiodo-
18. Iomeprolum [inn-latin]
19. Unii-17e17jbp8l
20. Iomeprol [usan:inn:ban:jan]
21. Iomeprol [usan]
22. Iomeprol [inn]
23. Iomeprol [jan]
24. Iomeprol [mi]
25. Iomeron 300 (tn)
26. Iomeprol [mart.]
27. Iomeprol [who-dd]
28. Dsstox_cid_28987
29. Dsstox_rid_83252
30. Dsstox_gsid_49061
31. Schembl26981
32. Iomeprol (jan/usan/inn)
33. Chembl2107214
34. Dtxsid1049061
35. Bcp34386
36. Tox21_113611
37. Akos030255901
38. Db11705
39. Ac-30722
40. Cas-78649-41-9
41. Db-056324
42. Ft-0627277
43. Ft-0670399
44. Methylacetamido)-2,4,6-triiodoisophthalamide
45. D01719
46. Iomeprol 100 Microg/ml In Acetonitrile/methanol
47. Iomeprol 100 Microg/ml In Acetonitrile:methanol
48. A839467
49. B-16880
50. N1,n3-bis(2,3-dihydroxypropyl)-5-(2-hydroxy-n-
51. Q6062808
52. 1,3-benzenedicarboxamide, N1,n3-bis(2,3-dihydroxypropyl)-5-[(2-hydroxyacetyl)methylamino]-2,4,6-triiodo-
Molecular Weight | 777.1 g/mol |
---|---|
Molecular Formula | C17H22I3N3O8 |
XLogP3 | -2.3 |
Hydrogen Bond Donor Count | 7 |
Hydrogen Bond Acceptor Count | 8 |
Rotatable Bond Count | 10 |
Exact Mass | 776.8541 g/mol |
Monoisotopic Mass | 776.8541 g/mol |
Topological Polar Surface Area | 180 Ų |
Heavy Atom Count | 31 |
Formal Charge | 0 |
Complexity | 591 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 2 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Contrast Media
Substances used to allow enhanced visualization of tissues. (See all compounds classified as Contrast Media.)
V08AB10
S76 | LUXPHARMA | Pharmaceuticals Marketed in Luxembourg | Pharmaceuticals marketed in Luxembourg, as published by d'Gesondheetskeess (CNS, la caisse nationale de sante, www.cns.lu), mapped by name to structures using CompTox by R. Singh et al. (in prep.). List downloaded from https://cns.public.lu/en/legislations/textes-coordonnes/liste-med-comm.html. Dataset DOI:10.5281/zenodo.4587355
V - Various
V08 - Contrast media
V08A - X-ray contrast media, iodinated
V08AB - Watersoluble, nephrotropic, low osmolar x-ray contrast media
V08AB10 - Iomeprol
Global Sales Information
Market Place
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?